Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on October 11, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,769 cr
Turnover Ratio
16.09%
Expense Ratio
0.90%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 1.02%
- 1Y: 52.43%
- 3M: 14.51%
- 3Y: 20.48%
- 6M: 22.73%
- 5Y: 31.75%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
17.755 | 66.39% | 432 cr | 0.69% | - | ||
41.910 | 63.90% | 4,987 cr | 1.06% | - | ||
36.039 | 58.51% | 1,208 cr | 0.72% | - | ||
479.545 | 53.91% | 3,346 cr | 0.89% | - |
Other plans of Nippon India Pharma